Bharat K. Trivedi - Concepedia

Author

Bharat K. Trivedi

Also Known As

B K TRIVEDI, B K Trivedi, B. K. TRIVEDI, B. K. Trivedi, B. Trivedi, B.K. Trivedi, Bharat K Trivedi, Bharat K. Trivedi, Bharat.K. Trivedi, Bhargav Trivedi

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory Pfizer (United States)University of California, Davis Plymouth Marine Laboratory

About

Bharat K. Trivedi is an author at Warde Medical Laboratory specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	1.2K
2	Natural Sciences	14	19	702
3	Health Sciences	2	2	26
4	Public Health	2	2	26
5	Engineering	1	1	11

Bharat K. Trivedi

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants William A. Pryor, Joseph A. Cornicelli, Larry J. Devall, The Journal of Organic Chemistry Antioxidant PotenciesBiochemistryMedicineLipid PeroxidationAltmetric Attention Score	1993	296
Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties Sandra M. Sendobry, Joseph A. Cornicelli, Kathryn Welch, British Journal of Pharmacology	1997	177
Novel Nonpeptide CCK-B Antagonists: Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists Janak Padia, Mark J. Field, Joanna P. Hinton, Journal of Medicinal Chemistry	1998	85
N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor Alexander J. Bridges, Robert F. Bruns, Daniel F. Ortwine, Journal of Medicinal Chemistry Novel Adenosine AgonistsMolecular PharmacologyMolecular SciencesBiochemistryAdenosine A2 Receptor	1988	81
15-Lipoxygenase and Its Inhibition: A Novel Therapeutic Target for Vascular Disease Joseph A. Cornicelli, Bharat K. Trivedi Current Pharmaceutical Design Vascular DiseaseLipid PeroxidationImmunologyHyperlipidemiaNovel Therapeutic Target	1999	81
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents Bruce D. Roth, C. John Blankley, M. L. HOEFLE, Journal of Medicinal Chemistry Chemical BiologyPharmaceutical ChemistryMedicinal ChemistryFatty Acid AnilidesPharmacological Study	1992	67
N6-Bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor Bharat K. Trivedi, Alexander J. Bridges, William C. Patt, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyAdenosine A1 ReceptorbMolecular Pharmacology	1989	57
Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors William K.C. Park, Robert M. Kennedy, Scott D. Larsen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryHmg-coa Reductase InhibitorsOxysterolBiochemistryMedicine	2007	55
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors Jeffrey A. Pfefferkorn, Yuntao Song, Kuai-Lin Sun, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacology	2007	55
Inhibitors of acyl-CoA:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents Bharat K. Trivedi, Ann Holmes, Terri L. Stoeber, Journal of Medicinal Chemistry	1993	54

Page 1